Jonathan E. Lim - 08 Jun 2023 Form 4 Insider Report for Erasca, Inc. (ERAS)

Role: Chairman & CEO, Director, 10%+ Owner
Signature: /s/ Ebun Garner, attorney-in-fact
Issuer symbol: ERAS
Transactions as of: 08 Jun 2023
Net transactions value: +$275,000
Form type: 4
Filing time: 08 Jun 2023, 20:54:06 UTC
Previous filing: 26 Jun 2023
Next filing: 10 Oct 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ERAS	Common Stock	Purchase	$275,000	+100,000	+0.55%	$2.75	18,396,216	08 Jun 2023	By Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005	F1
holding	ERAS	Common Stock						11,899,360	08 Jun 2023	By City Hill, LLC	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.
F2	Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.

Content

The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.

Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Lim disclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.